Convatec Group PLC (CTEC)

Industry Medical Instruments & Supplies


This stock can be held in an Investment ISA, SIPP and Investment Account
Sell

229.40p

Buy

229.80p

arrow-up0.60p (+0.26%)

Prices updated at 12 Dec 2025, 17:00 GMT
| Prices minimum 15 mins delay
|
Prices in GBX

ConvaTec Group PLC is a medical products and technologies company focused on therapies for the management of chronic conditions offering wound care, ostomy care, continence and critical care, and infusion devices.

Income statement

20232024
2,142m2,289m
1,201m1,284m
265m332m
12.3814.49
130m191m
456m540m
Sales, General and administrative825m840m
Interest expenses73m74m
Provision for income taxes37m56m
Operating expenses935m952m
Income before taxes167m246m
Net income available to common shareholders130m191m
0.0640.093
Net interest income-75m-78m
Advertising and promotion--
Net investment income, net4m-18m
Realised capital gains (losses), net--
Total benefits, claims and expenses--
Earnings per share (diluted)0.0630.093
Free cash flow per share0.04390.0998
Book value/share0.62410.6451
Debt equity ratio0.76310.698443

Balance sheet

20232024
Current assets870m793m
Current liabilities536m512m
Total capital2,920m2,812m
Total debt1,312m1,202m
Total equity1,693m1,689m
Total non current liabilities--
Loans1,227m1,123m
Total assets3,714m3,515m
Total liabilities--
Cash and cash equivalents98m65m
Common stock2,046m2,044m

Cash flow

20232024
Cash at beginning of period144m98m
Cash dividends paid-111m-130m
238m274m
Investments (gains) losses-286m-161m
98m65m
Net income--
367m396m
-129m-122m
The figures shown in the tables are quoted in the currency of the stock selected.
Please note that past performance is not a reliable indicator of future returns. Please use the interactive graph for benchmark comparison.


Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.
© Copyright 2025 Morningstar. All rights reserved.